Keywords: Bone, MR-Guided Interventions, cryoablationOsteosarcoma (OSA) is the most common bone cancer in young adults and dogs and almost invariably lethal when the cancer spreads. MR-guided cryoablation offers the potential to cause direct bone necrosis and palliative pain management and has shown the potential to upregulate the immune response in prostate and breast cancer to prevent or shrink metastatic disease. The current study seeks to determine the immune response of MR-guided cryoablation in spontaneously occurring canine osteosarcoma in comparison to X-ray-guided intratumoral Stimulator of Interferon Gene (STING) immunotherapy as determine by survival time and measurement of inflammatory infilitrates.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords